A policy group's review calls the city's mass shooting response "highly effective;" it also shows dangers of early disconnect ...

The U.S. Food and Drug Administration has authorized Aletta as the first standalone robotic device that can draw blood from a patient's arm. Marketing authorization was granted to Vitestro. The device ...

THURSDAY, Aug. 20, 2026 (HealthDay News) -- The U.S. Food and Drug Administration has authorized the Aletta as the first standalone robotic device that can draw blood from a patient's arm. The device ...

(WKBN) -- The FDA has just approved a robotic device that can draw blood from a human without "hands-on" operator intervention. Aletta is the first standalone robotic device approved for this purpose.

Vitestro received FDA authorization for Aletta, a standalone robotic device capable of drawing blood from a patient's arm without hands-on operator involvement. The FDA granted the authorization ...

The FDA has approved Vitestro’s Aletta as the first standalone robotic device in the U.S. designed to draw blood without the need for hands-on human help. The approval, the FDA said in a release, will ...

The FDA authorized Aletta, the first standalone robotic device that can draw blood from an adult patient’s arm without hands-on operator intervention. The robot finds a suitable vein and autonomously ...

Add Yahoo as a preferred source to see more of our stories on Google. Vitestro CEO and co-founder Toon Overbeeke with Aletta, the company's device for autonomous blood draws. The Food and Drug ...

WASHINGTON — The U.S. Food and Drug Administration on Wednesday authorized the first standalone robotic device that can draw blood from a patient’s arm without a hands-on operator. The device, called ...